Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients. - Wikidata - wikimedia - TriplyDB

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

http://www.wikidata.org/entity/Q35036640

about

Evolution and function of the TCR Vgamma9 chain repertoire: It's good to be public.Epitope located N-glycans impair the MHC-I epitope generation and presentation.Marked anti-tumor effects of CD8(+)CD62L(+) T cells from melanoma-bearing mice.T Cell Receptor Profiling in Type 1 Diabetes.

P2860

Q35739148-E43FFCAE-C4A1-495B-95C7-B90565D958C8 Q41023840-A4220E68-DF0D-41D8-AB9C-15845E2BDA18 Q42200022-483A13C5-0939-4A94-A5EA-98CE91B9ECD6 Q42374922-D7E0B1BD-B90F-46D2-9E86-A0F6DBB8DB6B

P2860

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients.

http://www.wikidata.org/entity/Q35036640

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@ast

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@en

type

label

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@ast

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@en

prefLabel

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@ast

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@en

P1433

Q35036640-786BB0EA-5703-4661-9ABC-7B98938B50A0

P1476

Q35036640-86E88BE2-FAAF-4F2F-9FC1-1CB66B670117

P2093

Q35036640-0B5D064E-F2A9-4C39-B36D-006B6D405CFB

Q35036640-452D4B79-321C-4C3B-9776-F78EC60C20C9

Q35036640-456908AB-96A5-4D24-B9E9-98CD012224EF

Q35036640-49C34AD7-6F29-49FE-ADAA-2D02D846CE71

Q35036640-8A50B481-F472-4D3F-9EFD-653604317BCC

Q35036640-A672F84F-527E-4771-B0C2-FF52B0EC214A

Q35036640-D6770312-9EB7-4747-BB72-1988F31650C2

Q35036640-E869A250-1FCA-43B8-A0AB-E74965F22B33

Q35036640-F38E5047-45AE-4058-85C5-AECFC5867237

P2860

Q35036640-01E5A812-C7C6-4D37-9C57-414DB6D8C92F

Q35036640-07B1A570-44BB-4134-855D-2F320276B1E5

Q35036640-08D86E55-6C17-47FF-BB0F-7377582623CE

Q35036640-0A3F8243-B38B-44A3-A81B-669AF2F43F17

Q35036640-0CB2F61B-4348-449F-B065-77EBA0B279A2

Q35036640-0DF56A0D-5060-4694-9F44-0FF5EF7FFAF6

Q35036640-0E6FCF95-3440-4AA6-9064-8DF81BA69319

Q35036640-0FC223EE-5B2D-4906-94C2-8DC7A8D63458

Q35036640-1AA9992F-3375-442B-8B84-DD021F744E18

Q35036640-1ABD5508-D541-43AE-AFD3-AE9D9CBB3BB7

P304

Q35036640-E8C2D095-2826-4FF9-9186-E513680DE959

P31

Q35036640-655BD084-7B42-451B-AAF9-F768F08585F6

P356

Q35036640-DA260850-D354-47F2-A63E-759FEB7944AB

P407

Q35036640-7565DF36-8C73-42F4-BBC6-0BBB00DFCA2C

P433

Q35036640-4F76B462-748F-4D2D-A9C8-72096AA753EF

P478

Q35036640-8C84A8A6-7CCA-4895-ABFC-AD2C9E8E828D

P577

Q35036640-EAA89DDE-D3A5-40AC-A13E-55F21661E887

P5875

Q35036640-ACFE8AFA-E444-4E63-A2BA-110502B43856

P698

Q35036640-929FD770-5621-4D6C-AB80-C30088ABBA81

P932

Q35036640-4DBDADC9-FE46-4983-9480-7A444E70A123

P356

JOURNAL.PONE.0078686

P1433

P1476

Persistence of EBV antigen-spe ...... nstitution in cancer patients.

@en

P2093

Bhawna Gupta

http://www.w3.org/2001/XMLSchema#string

Daniel E Speiser

http://www.w3.org/2001/XMLSchema#string

Emanuela M Iancu

http://www.w3.org/2001/XMLSchema#string

Emanuela Romano

http://www.w3.org/2001/XMLSchema#string

Julien Laurent

http://www.w3.org/2001/XMLSchema#string

Nathalie Rufer

http://www.w3.org/2001/XMLSchema#string

Olivier Michielin

http://www.w3.org/2001/XMLSchema#string

Pedro Romero

http://www.w3.org/2001/XMLSchema#string

Philippe O Gannon

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cell memory in the context of persistent herpes viral infections

GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo

Genetic and Structural Basis for Selection of a Ubiquitous T Cell Receptor Deployed in Epstein-Barr Virus Infection

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

A phase I study of nonmyeloablative chemotherapy and adoptive transfer of autologous tumor antigen-specific T lymphocytes in patients with metastatic melanoma

Memory CD8+ T cell differentiation

Single cell analysis reveals similar functional competence of dominant and nondominant CD8 T-cell clonotypes

Transcriptional control of effector and memory CD8+ T cell differentiation.

P304

e78686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0078686

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258351461

http://www.w3.org/2001/XMLSchema#string

P698

24205294

http://www.w3.org/2001/XMLSchema#string

P932

3808305

http://www.w3.org/2001/XMLSchema#string